Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matcheri S Keshavan, M.D.

Co-Author

This page shows the publications co-authored by Matcheri Keshavan and William Stone.
Connection Strength

1.938
  1. Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China. JAMA Psychiatry. 2020 Nov 01; 77(11):1116-1126.
    View in: PubMed
    Score: 0.232
  2. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes. Schizophr Res. 2020 12; 226:138-146.
    View in: PubMed
    Score: 0.227
  3. Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology. Schizophr Res. 2020 06; 220:1-15.
    View in: PubMed
    Score: 0.223
  4. Effects of peer social interaction on performance during computerized cognitive remediation therapy in patients with early course schizophrenia: A pilot study. Schizophr Res. 2019 01; 203:17-23.
    View in: PubMed
    Score: 0.186
  5. Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2021 Oct 19; 238:137-144.
    View in: PubMed
    Score: 0.062
  6. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. Schizophr Bull. 2021 Sep 28.
    View in: PubMed
    Score: 0.062
  7. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis. Schizophr Bull. 2021 Sep 18.
    View in: PubMed
    Score: 0.062
  8. Abnormal Function in Dentate Nuclei Precedes the Onset of Psychosis: A Resting-State fMRI Study in High-Risk Individuals. Schizophr Bull. 2021 Aug 21; 47(5):1421-1430.
    View in: PubMed
    Score: 0.061
  9. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021 May 24.
    View in: PubMed
    Score: 0.060
  10. Comparison of social cognition using an adapted Chinese version of the Reading the Mind in the Eyes Test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China. Psychol Med. 2021 Mar 16; 1-13.
    View in: PubMed
    Score: 0.059
  11. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study. Schizophr Bull. 2021 03 16; 47(2):562-574.
    View in: PubMed
    Score: 0.059
  12. Individualized risk components guiding antipsychotic delivery in patients with a clinical high risk of psychosis: application of a risk calculator. Psychol Med. 2021 Feb 17; 1-10.
    View in: PubMed
    Score: 0.059
  13. Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD. Transl Psychiatry. 2021 01 28; 11(1):80.
    View in: PubMed
    Score: 0.059
  14. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophr Res. 2021 01; 227:72-77.
    View in: PubMed
    Score: 0.057
  15. Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program. Psychol Med. 2021 03; 51(4):653-660.
    View in: PubMed
    Score: 0.055
  16. Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis. Neuroimage Clin. 2020; 26:102108.
    View in: PubMed
    Score: 0.054
  17. Clinical subtypes that predict conversion to psychosis: A canonical correlation analysis study from the ShangHai At Risk for Psychosis program. Aust N Z J Psychiatry. 2020 05; 54(5):482-495.
    View in: PubMed
    Score: 0.053
  18. Altered Cellular White Matter But Not Extracellular Free Water on Diffusion MRI in Individuals at Clinical High Risk for Psychosis. Am J Psychiatry. 2019 10 01; 176(10):820-828.
    View in: PubMed
    Score: 0.053
  19. P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature. Schizophr Res. 2020 12; 226:74-83.
    View in: PubMed
    Score: 0.052
  20. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services. J Am Acad Child Adolesc Psychiatry. 2019 06; 58(6):582-588.
    View in: PubMed
    Score: 0.052
  21. Neural correlates of cognitive deficits across developmental phases of schizophrenia. Neurobiol Dis. 2019 11; 131:104353.
    View in: PubMed
    Score: 0.051
  22. Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program. Mol Psychiatry. 2020 10; 25(10):2431-2440.
    View in: PubMed
    Score: 0.050
  23. Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program. Am J Psychiatry. 2018 09 01; 175(9):906-908.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.